Specific glycoforms of MUC5AC and endorepellin accurately distinguish mucinous from nonmucinous pancreatic cysts

Molecular and Cellular Proteomics

Volumn 12, Issue 10, 2013, Pages 2724-2734

  Cao, Zheng ^a   Maupin, Kevin ^a   Curnutte, Bryan ^a   Fallon, Brian ^a   Feasley, Christa L ^b   Brouhard, Elizabeth ^a   Kwon, Richard ^c   West, Christopher M ^a   Cunningham, John ^d   Brand, Randall ^e   Castelli, Paola ^f   Crippa, Stefano ^f   Feng, Ziding ^g   Allen, Peter ^h   Simeone, Diane M ^c   Haab, Brian B ^a  

^a VAN ANDEL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^f SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

^g Fred Hutchinson Cancer Research Center   (United States)

^h MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIBODY; BLOOD GROUP H ANTIBODY; BRADYKININ; CARCINOEMBRYONIC ANTIGEN; CORE PROTEIN; ENDOREPELLIN; GLYCAN; LECTIN; MUCIN 5AC; PERLECAN; PROTEIN; UNCLASSIFIED DRUG; WHEAT GERM AGGLUTININ;

ARTICLE; CONTROLLED STUDY; CYST FLUID; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; GLYCOSYLATION; HUMAN; HUMAN TISSUE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MUCINOUS PANCREATIC CYST; NONMUCINOUS PANCREATIC CYST; PANCREAS CYST; PRIORITY JOURNAL; PROTEIN ANALYSIS; SENSITIVITY AND SPECIFICITY; UPREGULATION;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CYST FLUID; FEMALE; GLYCOSYLATION; HEPARAN SULFATE PROTEOGLYCANS; HUMANS; MALE; MIDDLE AGED; MUCIN 5AC; PANCREATIC CYST; PEPTIDE FRAGMENTS; POLYSACCHARIDES; YOUNG ADULT;

EID: 84885160723     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M113.030700     Document Type: Article

References (52)

1. Matthaei, H., Schulick, R. D., Hruban, R. H., and Maitra, A. (2011) Cystic precursors to invasive pancreatic cancer. Nat. Rev. Gastroenterol. Hepatol. 8, 141-150
2. van der Waaij, L. A., van Dullemen, H. M., and Porte, R. J. (2005) Cyst fluid analysis in the differential diagnosis of pancreatic cystic lesions: a pooled analysis. Gastrointest. Endosc. 62, 383-389
3. Brugge, W. R., Lewandrowski, K., Lee-Lewandrowski, E., Centeno, B. A., Szydlo, T., Regan, S., del Castillo, C. F., and Warshaw, A. L. (2004) Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 126, 1330-1336
4. Nagula, S., Kennedy, T., Schattner, M. A., Brennan, M. F., Gerdes, H., Markowitz, A. J., Tang, L., and Allen, P. J. (2010) Evaluation of cyst fluid CEA analysis in the diagnosis of mucinous cysts of the pancreas. J. Gastrointest. Surg. 12, 1997-2003
5. Khalid, A., Zahid, M., Finkelstein, S. D., LeBlanc, J. K., Kaushik, N., Ahmad, N., Brugge, W. R., Edmundowicz, S. A., Hawes, R. H., and McGrath, K. M. (2009) Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the panda study. Gastrointest. Endosc. 69, 1095-1102
6. Wu, J., Matthaei, H., Maitra, A., Dal Molin, M., Wood, L. D., Eshleman, J. R., Goggins, M., Canto, M. I., Schulick, R. D., Edil, B. H., Wolfgang, C. L., Klein, A. P., Diaz, L. A., Jr., Allen, P. J., Schmidt, C. M., Kinzler, K. W., Papadopoulos, N., Hruban, R. H., and Vogelstein, B. (2011) Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci. Transl. Med. 3, 92ra66
7. Wu, J., Jiao, Y., Dal Molin, M., Maitra, A., de Wilde, R. F., Wood, L. D., Eshleman, J. R., Goggins, M. G., Wolfgang, C. L., Canto, M. I., Schulick, R. D., Edil, B. H., Choti, M. A., Adsay, V., Klimstra, D. S., Offerhaus, G. J., Klein, A. P., Kopelovich, L., Carter, H., Karchin, R., Allen, P. J., Schmidt, C. M., Naito, Y., Diaz, L. A., Jr., Kinzler, K. W., Papadopoulos, N., Hruban, R. H., and Vogelstein, B. (2011) Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc. Natl. Acad. Sci. U. S. A. 108, 21188-21193
8. Raty, S., Sand, J., Alfthan, H., Haglund, C., and Nordback, I. (2004) Cyst fluid tumor-associated trypsin inhibitor may be helpful in the differentiation of cystic pancreatic lesions. J. Gastrointest. Surg. 8, 569-574
9. Ryu, J. K., Matthaei, H., Dal Molin, M., Hong, S. M., Canto, M. I., Schulick, R. D., Wolfgang, C., Goggins, M. G., Hruban, R. H., Cope, L., and Maitra, A. (2011) Elevated microrna mir-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma. Pancreatology 11, 343-350
10. Maker, A. V., Katabi, N., Qin, L. X., Klimstra, D. S., Schattner, M., Brennan, M. F., Jarnagin, W. R., and Allen, P. J. (2011) Cyst fluid interleukin-1beta (il1beta) levels predict the risk of carcinoma in intraductal papillary mucinous neoplasms of the pancreas. Clin. Cancer Res. 17, 1502-1508
11. Shami, V. M., Sundaram, V., Stelow, E. B., Conaway, M., Moskaluk, C. A., White, G. E., Adams, R. B., Yeaton, P., and Kahaleh, M. (2007) The level of carcinoembryonic antigen and the presence of mucin as predictors of cystic pancreatic mucinous neoplasia. Pancreas 34, 466-469
12. Hammel, P. R., Forgue-Lafitte, M. E., Levy, P., Voitot, H., Vilgrain, V., Flejou, J. F., Molas, G., Gespach, C., Ruszniewski, P., Bernades, P., and Bara, J. (1997) Detection of gastric mucins (m1 antigens) in cyst fluid for the diagnosis of cystic lesions of the pancreas. Int. J. Cancer 74, 286-290
13. Mann, B. F., Goetz, J. A., House, M. G., Schmidt, C. M., and Novotny, M. V. Glycomic and proteomic profiling of pancreatic cyst fluids identifies hyperfucosylated lactosamines on the N-linked glycans of overexpressed glycoproteins. Mol. Cell. Proteomics 11, M111.015792
14. Cuoghi, A., Farina, A., Z'Graggen, K., Dumonceau, J. M., Tomasi, A., Hochstrasser, D. F., Genevay, M., Lescuyer, P., and Frossard, J. L. (2011) Role of proteomics to differentiate between benign and potentially malignant pancreatic cysts. J. Proteome Res. 10, 2664-2670
15. Visser, B. C., Yeh, B. M., Qayyum, A., Way, L. W., McCulloch, C. E., and Coakley, F. V. (2007) Characterization of cystic pancreatic masses: relative accuracy of CT and MRI. AJR Am. J. Roentgenol. 189, 648-656
16. Haab, B. B., Porter, A., Yue, T., Li, L., Scheiman, J., Anderson, M. A., Barnes, D., Schmidt, C. M., Feng, Z., and Simeone, D. (2010) Glycosylation variants of mucins and CEACAMs as candidate biomarkers for the diagnosis of pancreatic cystic neoplasms. Ann. Surg. 251, 937-945
17. Lau, K. S., and Dennis, J. W. (2008) N-glycans in cancer progression. Glycobiology 18, 750-760
18. Wang, Y., Ju, T., Ding, X., Xia, B., Wang, W., Xia, L., He, M., and Cummings, R. D. (2010) Cosmc is an essential chaperone for correct protein O-glycosylation. Proc. Natl. Acad. Sci. U. S. A. 107, 9228-9233
19. Okuyama, N., Ide, Y., Nakano, M., Nakagawa, T., Yamanaka, K., Moriwaki, K., Murata, K., Ohigashi, H., Yokoyama, S., Eguchi, H., Ishikawa, O., Ito, T., Kato, M., Kasahara, A., Kawano, S., Gu, J., Taniguchi, N., and Miyoshi, E. (2006) Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int. J. Cancer 118, 2803-2808
20. Dennis, J. W., Granovsky, M., and Warren, C. E. (1999) Glycoprotein glycosylation and cancer progression. Biochim. Biophys. Acta 1473, 21-34
21. Yue, T., Goldstein, I. J., Hollingsworth, M. A., Kaul, K., Brand, R. E., and Haab, B. B. (2009) The prevalence and nature of glycan alterations on specific proteins in pancreatic cancer patients revealed using antibodylectin sandwich arrays. Mol. Cell. Proteomics 8, 1697-1707
22. Yue, T., Maupin, K. A., Fallon, B., Li, L., Partyka, K., Anderson, M. A., Brenner, D. E., Kaul, K., Zeh, H., Moser, A. J., Simeone, D. M., Feng, Z., Brand, R. E., and Haab, B. B. (2011) Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers. PLoS One 6, e29180
23. Chen, S., LaRoche, T., Hamelinck, D., Bergsma, D., Brenner, D., Simeone, D., Brand, R. E., and Haab, B. B. (2007) Multiplexed analysis of glycan variation on native proteins captured by antibody microarrays. Nat. Methods 4, 437-444
24. Haab, B. B. (2010) Antibody-lectin sandwich arrays for biomarker and glycobiology studies. Expert Rev. Proteomics 7, 9-11
25. Partyka, K., McDonald, M., Maupin, K. A., Brand, R., Kwon, R., Simeone, D. M., Allen, P., and Haab, B. B. (2012) Comparison of surgical and endoscopic sample collection for pancreatic cyst fluid biomarker identification. J. Proteome Res. 11, 2904-2911
26. Haab, B. B., and Yue, T. (2011) High-throughput studies of protein glycoforms using antibody-lectin sandwich arrays. Methods Mol. Biol. 785, 223-236
27. Feasley, C. L., Johnson, J. M., West, C. M., and Chia, C. P. (2010) Glycopeptidome of a heavily N-glycosylated cell surface glycoprotein of dictyostelium implicated in cell adhesion. J. Proteome Res. 9, 3495-3510
28. West, M. B., Segu, Z. M., Feasley, C. L., Kang, P., Klouckova, I., Li, C., Novotny, M. V., West, C. M., Mechref, Y., and Hanigan, M. H. (2010) Analysis of site-specific glycosylation of renal and hepatic gamma-glutamyl transpeptidase from normal human tissue. J. Biol. Chem. 285, 29511-29524
29. Kang, P., Mechref, Y., and Novotny, M. V. (2008) High-throughput solidphase permethylation of glycans prior to mass spectrometry. Rapid Commun. Mass Spectrom. 22, 721-734
30. Ceroni, A., Dell, A., and Haslam, S. M. (2007) The GlycanBuilder: a fast, intuitive and flexible software tool for building and displaying glycan structures. Source Code Biol. Med. 2, 3
31. Ceroni, A., Maass, K., Geyer, H., Geyer, R., Dell, A., and Haslam, S. M. (2008) GlycoWorkbench: a tool for the computer-assisted annotation of mass spectra of glycans. J. Proteome Res. 7, 1650-1659
32. Fallon, B. P., Curnutte, B., Maupin, K. A., Partyka, K., Choi, S., Brand, R. E., Langmead, C. J., Tembe, W., and Haab, B. B. (2013) The Marker State Space (MSS) method for classifying clinical samples. PLoS One. 8, e65905 In press
33. Maker, A. V., Katabi, N., Gonen, M., Dematteo, R. P., D'Angelica, M. I., Fong, Y., Jarnagin, W. R., Brennan, M. F., and Allen, P. J. (2010) Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas. Ann. Surg. Oncol. 18, 199-206
34. Porter, A., Yue, T., Heeringa, L., Day, S., Suh, E., and Haab, B. B. (2010) A motif-based analysis of glycan array data to determine the specificities of glycan-binding proteins. Glycobiology 20, 369-380
35. Babu, P., North, S. J., Jang-Lee, J., Chalabi, S., Mackerness, K., Stowell, S. R., Cummings, R. D., Rankin, S., Dell, A., and Haslam, S. M. (2009) Structural characterisation of neutrophil glycans by ultra sensitive mass spectrometric glycomics methodology. Glycoconj. J. 26, 975-986
36. Knezevic, A., Polasek, O., Gornik, O., Rudan, I., Campbell, H., Hayward, C., Wright, A., Kolcic, I., O'Donoghue, N., Bones, J., Rudd, P. M., and Lauc, G. (2009) Variability, heritability and environmental determinants of human plasma N-glycome. J. Proteome Res. 8, 694-701
37. Wu, J. T. (1990) Serum alpha-fetoprotein and its lectin reactivity in liver diseases: a review. Ann. Clin. Lab. Sci. 20, 98-105
38. Miyoshi, E., and Nakano, M. (2008) Fucosylated haptoglobin is a novel marker for pancreatic cancer: detailed analyses of oligosaccharide structures. Proteomics 8, 3257-3262
39. Parekh, R. B., Dwek, R. A., Sutton, B. J., Fernandes, D. L., Leung, A., Stanworth, D., Rademacher, T. W., Mizuochi, T., Taniguchi, T., Matsuta, K., Takeuchi, F., Nagano Y., Miyamoto, T., and Kobata, A. (1985) Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature 316, 452-457
40. Cremonesi, L., Ferrari, M., Giordano, P. C., Harteveld, C. L., Kleanthous, M., Papasavva, T., Patrinos, G. P., and Traeger-Synodinos, J. (2007) An overview of current microarray-based human globin gene mutation detection methods. Hemoglobin 31, 289-311
41. Sato, N., Fukushima, N., Maitra, A., Iacobuzio-Donahue, C. A., van Heek, N. T., Cameron, J. L., Yeo, C. J., Hruban, R. H., and Goggins, M. (2004) Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas. Am. J. Pathol. 164, 903-914
42. Wu, Y. M., Nowack, D. D., Omenn, G. S., and Haab, B. B. (2009) Mucin glycosylation is altered by pro-inflammatory signaling in pancreaticcancer cells. J. Proteome Res. 8, 1876-1886
43. Whitelock, J. M., Melrose, J., and Iozzo, R. V. (2008) Diverse cell signaling events modulated by perlecan. Biochemistry 47, 11174-11183
44. Mongiat, M., Sweeney, S. M., San Antonio, J. D., Fu, J., and Iozzo, R. V. (2003) Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan. J. Biol. Chem. 278, 4238-4249
45. Tachezy, M., Reichelt, U., Melenberg, T., Gebauer, F., Izbicki, J. R., and Kaifi, J. T. (2010) Angiogenesis index cd105 (endoglin)/cd31 (pecam-1) as a predictive factor for invasion and proliferation in intraductal papillary mucinous neoplasm (IPMN) of the pancreas. Histol. Histopathol. 25, 1239-1246
46. Kanno, A., Satoh, K., Kimura, K., Hirota, M., Umino, J., Masamune, A., Satoh, A., Asakura, T., Egawa, S., Sunamura, M., Endoh, M., and Shimosegawa, T. (2006) The expression of MUC4 and MUC5AC is related to the biologic malignancy of intraductal papillary mucinous neoplasms of the pancreas. Pancreas 33, 391-396
47. Inaguma, S., Kasai, K., and Ikeda, H. (2011) GLI1 facilitates the migration and invasion of pancreatic cancer cells through MUC5AC-mediated attenuation of E-cadherin. Oncogene 30, 714-723
48. Rausch, P., Rehman, A., Kunzel, S., Hasler, R., Ott, S. J., Schreiber, S., Rosenstiel, P., Franke, A., and Baines, J. F. (2011) Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (secretor) genotype. Proc. Natl. Acad. Sci. U. S. A. 108, 19030-19035
49. Hasehira, K., Tateno, H., Onuma, Y., Ito, Y., Asashima, M., and Hirabayashi, J. (2012) Structural and quantitative evidence for dynamic glycome shift on production of induced pluripotent stem cells. Mol. Cell. Proteomics 11, 1913-1923
50. Satomaa, T., Heiskanen, A., Mikkola, M., Olsson, C., Blomqvist, M., Tiittanen, M., Jaatinen, T., Aitio, O., Olonen, A., Helin, J., Hiltunen, J., Natunen, J., Tuuri, T., Otonkoski, T., Saarinen, J., and Laine, J. (2009) The N-glycome of human embryonic stem cells. BMC Cell Biol. 10, 42
51. Satomaa, T., Heiskanen, A., Leonardsson, I., Angstrom, J., Olonen, A., Blomqvist, M., Salovuori, N., Haglund, C., Teneberg, S., Natunen, J., Carpen, O., and Saarinen, J. (2009) Analysis of the human cancer glycome identifies a novel group of tumor-associated N-acetylglucosamine glycan antigens. Cancer Res. 69, 5811-5819
52. Kobayashi, M., Lee, H., Nakayama, J., and Fukuda, M. (2009) Roles of gastric mucin-type O-glycans in the pathogenesis of Helicobacter pylori infection. Glycobiology 19, 453-461